Limbic system-associated membrane protein

LSAMP
Identifiers
AliasesLSAMP, IGLON3, LAMP, limbic system-associated membrane protein, limbic system associated membrane protein
External IDsOMIM: 603241; MGI: 1261760; GeneCards: LSAMP
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

4045

268890

Ensembl

ENSG00000185565

ENSMUSG00000061080

UniProt

Q13449

Q8BLK3

RefSeq (mRNA)

NM_002338
NM_001318915

NM_175548
NM_001347236

RefSeq (protein)

NP_001305844
NP_002329

NP_001334165
NP_001348210
NP_001348211

Location (UCSC)Chr 3: 115.8 – 117.14 MbChr 16: 39.98 – 42.18 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Limbic system-associated membrane protein (shortened to LSAMP or LAMP) is a protein which in humans is encoded by the gene LSAMP.

Structure

LSAMP is a 64- to 68-kDa heavily glycosylated protein.

Tissue distribution

LSAMP is found in neurons, specifically it is distributed in cortical and subcortical regions of the limbic system.[5]

Subcellular distribution

LSAMP protein is expressed on the surface of somata and proximal dendrites of neurons where it integrates via glycosyl-phosphatidyl-inositol (GPI) anchor.[6] Despite the name, LSAMP is not expressed only in the limbic-associated areas, but also less intensely in the midbrain and hindbrain regions.[6]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000185565 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000061080 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Pimenta AF, Fischer I, Levitt P (May 1996). "cDNA cloning and structural analysis of the human limbic-system-associated membrane protein (LAMP)". Gene. 170 (2): 189–195. doi:10.1016/0378-1119(96)84698-1. PMID 8666243.
  6. 1 2 Innos J, Koido K, Philips MA, Vasar E (2013). "Limbic system associated membrane protein as a potential target for neuropsychiatric disorders". Frontiers in Pharmacology. 4 32. doi:10.3389/fphar.2013.00032. PMC 3607788. PMID 23532449.